{"id":"https://openalex.org/W4396872079","doi":"https://doi.org/10.59556/japi.71.0444","title":"Phase IV Studies: What Clinicians Need to Know!","display_name":"Phase IV Studies: What Clinicians Need to Know!","publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4396872079","doi":"https://doi.org/10.59556/japi.71.0444","pmid":"https://pubmed.ncbi.nlm.nih.gov/38736079"},"language":"en","primary_location":{"id":"doi:10.59556/japi.71.0444","doi":"https://doi.org/10.59556/japi.71.0444","is_oa":false,"landing_page_url":"https://doi.org/10.59556/japi.71.0444","pdf_url":null,"source":{"id":"https://openalex.org/S957094277","display_name":"Journal of the Association of Physicians of India","issn_l":"0004-5772","issn":["0004-5772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318712","host_organization_name":"Association of Physicians of India","host_organization_lineage":["https://openalex.org/P4310318712"],"host_organization_lineage_names":["Association of Physicians of India"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Association of Physicians of India","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026103644","display_name":"Abhijit Trailokya","orcid":"https://orcid.org/0009-0002-7657-8119","observed_orcids":["https://orcid.org/0009-0002-7657-8119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhijit Trailokya","raw_affiliation_strings":["Head, Department of Medical Affairs, Indoco Remedies Limited, Mumbai, Maharashtra, India, Corresponding Author"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head, Department of Medical Affairs, Indoco Remedies Limited, Mumbai, Maharashtra, India, Corresponding Author","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106266921","display_name":"Ambrish Srivastava","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ambrish Srivastava","raw_affiliation_strings":["Consultant, Clinical Research and Drug Development, Ahmedabad, Gujarat, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant, Clinical Research and Drug Development, Ahmedabad, Gujarat, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023413031","display_name":"Qayum I Mukaddam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qayum Mukaddam","raw_affiliation_strings":["Independent Pharma Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Independent Pharma Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025491152","display_name":"Sunil Chaudhry","orcid":"https://orcid.org/0000-0002-5863-3025","observed_orcids":["https://orcid.org/0000-0002-5863-3025"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunil Chaudhry","raw_affiliation_strings":["Director and Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director and Consultant, Department of Solutions, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103059376","display_name":"Kamlesh Patel","orcid":"https://orcid.org/0009-0003-3084-6306","observed_orcids":["https://orcid.org/0009-0003-3084-6306"]},"institutions":[{"id":"https://openalex.org/I21675474","display_name":"Lupin Pharmaceuticals (India)","ror":"https://ror.org/04wdr7416","country_code":"IN","type":"company","lineage":["https://openalex.org/I21675474"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Kamlesh Patel","raw_affiliation_strings":["Head, Department of Medical and Health Technology, Lupin Limited, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head, Department of Medical and Health Technology, Lupin Limited, Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I21675474"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Sachin Suryawanshi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098465","display_name":"Emcure Pharmaceuticals (India)","ror":"https://ror.org/00zkm9w64","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210098465"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sachin Suryawanshi","raw_affiliation_strings":["Director, Medical Services Emcure Pharmaceutical Ltd., Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Director, Medical Services Emcure Pharmaceutical Ltd., Mumbai, Maharashtra, India","institution_ids":["https://openalex.org/I4210098465"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110612566","display_name":"Manoj Naik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manoj Naik","raw_affiliation_strings":["Head, Department of Clinical Operations and Pharmacovigilance, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Head, Department of Clinical Operations and Pharmacovigilance, Edenwell Therapeutics Private Limited, Mumbai, Maharashtra, India","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1972,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71610404,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"72","issue":"1","first_page":"85","last_page":"87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9375,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.035599999129772186,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.953000009059906},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7369999885559082},{"id":"https://openalex.org/keywords/late-effects","display_name":"late effects","score":0.8040000200271606},{"id":"https://openalex.org/keywords/real-world-effectiveness","display_name":"real-world effectiveness","score":0.9390000104904175},{"id":"https://openalex.org/keywords/regulatory-oversight","display_name":"regulatory oversight","score":0.5550000071525574},{"id":"https://openalex.org/keywords/good-clinical-practice","display_name":"good clinical practice","score":0.921999990940094},{"id":"https://openalex.org/keywords/medical-devices","display_name":"medical devices","score":0.453000009059906}],"concepts":[{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.7805690765380859},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.727403998374939},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5733254551887512},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.48758071660995483},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.4666011333465576},{"id":"https://openalex.org/C44280652","wikidata":"https://www.wikidata.org/wiki/Q104837","display_name":"Phase (matter)","level":2,"score":0.46643948554992676},{"id":"https://openalex.org/C2778150722","wikidata":"https://www.wikidata.org/wiki/Q1537519","display_name":"Good clinical practice","level":3,"score":0.4331289529800415},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.42285022139549255},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.42270219326019287},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.41876351833343506},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36485224962234497},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3201959431171417},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.30913084745407104},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08533519506454468},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D017327","descriptor_name":"Clinical Trials, Phase IV as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.59556/japi.71.0444","doi":"https://doi.org/10.59556/japi.71.0444","is_oa":false,"landing_page_url":"https://doi.org/10.59556/japi.71.0444","pdf_url":null,"source":{"id":"https://openalex.org/S957094277","display_name":"Journal of the Association of Physicians of India","issn_l":"0004-5772","issn":["0004-5772"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","norway-1","poland-40","russia-white-list-3"],"host_organization":"https://openalex.org/P4310318712","host_organization_name":"Association of Physicians of India","host_organization_lineage":["https://openalex.org/P4310318712"],"host_organization_lineage_names":["Association of Physicians of India"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the Association of Physicians of India","raw_type":"journal-article"},{"id":"pmid:38736079","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38736079","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of the Association of Physicians of India","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W2158131645","https://openalex.org/W2314578678","https://openalex.org/W2792649388","https://openalex.org/W3044098368","https://openalex.org/W3173670033","https://openalex.org/W4233308443","https://openalex.org/W4242887325","https://openalex.org/W6604910965"],"related_works":["https://openalex.org/W6892397635","https://openalex.org/W4401667000","https://openalex.org/W4414185985","https://openalex.org/W4415782017","https://openalex.org/W4248397712","https://openalex.org/W7159579004","https://openalex.org/W4255362632","https://openalex.org/W4244476675","https://openalex.org/W1540760709","https://openalex.org/W2560310721"],"abstract_inverted_index":{"Phase":[0],"IV":[1,62,88],"trials,":[2,89],"also":[3],"known":[4],"as":[5],"postmarketing":[6,12],"safety":[7,116],"and":[8,11,27,46,52,113,135],"efficacy":[9],"studies":[10,99],"surveillance":[13],"(PMS)":[14],"studies,":[15],"occur":[16],"after":[17],"a":[18,50,122],"drug":[19],"or":[20,69,94],"medical":[21],"device":[22],"has":[23],"received":[24],"regulatory":[25,119],"approval":[26],"is":[28,64],"available":[29],"in":[30,49,124,136],"the":[31,42,80,105],"market.":[32],"These":[33],"trials":[34,63,127],"are":[35,132],"designed":[36],"to":[37,65,100,128],"collect":[38],"additional":[39],"information":[40],"regarding":[41],"product's":[43],"safety,":[44],"efficacy,":[45],"prolonged":[47],"effects":[48,72],"larger":[51],"more":[53],"diverse":[54],"patient":[55],"population.":[56],"The":[57,118],"foremost":[58],"goal":[59],"of":[60,83,104],"phase":[61,87],"detect":[66],"any":[67,114],"rare":[68],"long-term":[70],"adverse":[71],"that":[73,130],"may":[74],"not":[75],"have":[76],"been":[77],"identified":[78],"during":[79],"prior":[81],"phases":[82],"clinical":[84,140],"development.":[85],"During":[86],"pharmaceutical":[90],"companies,":[91],"academic":[92],"institutions,":[93],"other":[95],"research":[96],"organizations":[97],"conduct":[98],"evaluate":[101],"various":[102],"aspects":[103],"product,":[106],"including":[107],"its":[108],"real-world":[109],"effectiveness,":[110],"optimal":[111],"use,":[112],"potential":[115],"concerns.":[117],"agencies":[120],"play":[121],"role":[123],"overseeing":[125],"these":[126],"ensure":[129],"they":[131],"conducted":[133],"ethically":[134],"compliance":[137],"with":[138],"good":[139],"practice":[141],"(GCP)":[142],"guidelines.":[143]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-05-14T00:00:00"}